USX:NERV - Minerva Neurosciences Inc Minerva Neurosciences Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 13 May 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)

USD 2.5    -0.07 (-2.72%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

27 Mar 2024


Loading...
Loading...
Loading...

General

CEO: Dr. Remy Luthringer Ph.D.

IPO: 2014-07-01

Headquarters: US

Employees: 9

Homepage

Description

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It  focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server J

About · FAQs · StocksCafe © 2024 · Privacy · Terms